Crovalimab. Anti-C5 monoclonal antibody, Treatment of paroxysmal nocturnal hemoglobinuria, Treatment of atypical hemolytic uremic syndrome, Treatment of vaso-occlusive crisis in sickle cell disease
-
Published:2022
Issue:12
Volume:47
Page:861
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Subject
Pharmacology (medical),Pharmacology